Fig. 4From: Intravitreal dexamethasone implant for central retinal vein occlusion without macular edemaRepresentative optical coherence tomography figures analyzing peripapillary retinal nerve fiber layer (RNFL) thickness of the optic nerve head (ONH) untreated (a) and Ozurdex-treated (b) central retinal vein occlusion eyes at each time point. RNFL thickening of ONH was prominent in both untreated (a) and Ozurdex-treated (b) eyes at baseline. It became thicker at 1 month and slightly decreased thereafter, but thickness remained above the normal range for up to 12 months in untreated eye (a). Conversely, in Ozurdex-treated eye (b), a significant improvement was observed at 1 month, and thickness gradually returned to its normal range during the follow-up periodBack to article page